Multiple Sclerosis Fast Facts

Nov 23, 2020 | health and medicine, Karger Publishers

In Collaboration With

Original Article Reference

This SciPod is a shortened and simplified summary of ‘Fast Facts: Multiple Sclerosis’ published by Karger Publishers: ISBN 978-1-910797-23-5

The complete original works are available at www.karger.com

Short on time? watch this 3 minute video

About this episode

Multiple sclerosis (MS) is a progressive disease of the nervous system resulting from the inflammation and degeneration of nerves. In developed countries, MS is the primary cause of neurological disability in young and middle-aged people. Worldwide, MS affects an estimated 2.3 million. The cause is unknown and although factors that may increase risk have been identified, attempts to curb disease progression have so far met with failure. However, we are at a turning point in scientific advancement with the emergence of promising new therapies that could help us shift the odds in our favor against this devastating disease.

Related episodes

Prof. Christian Bréchot | ALF5755: A New Therapeutic Avenue for Alzheimer’s and Diabetic Neuropathy

Prof. Christian Bréchot | ALF5755: A New Therapeutic Avenue for Alzheimer’s and Diabetic Neuropathy

Many diseases become more likely to emerge as we age, with metabolic disorders such as diabetes, and neurodegenerative conditions, such as Alzheimer’s disease, representing two frequent manifestations of poor health in old age. While many age-related diseases present very differently, many share common underlying mechanisms. These include inflammation, a build-up of reactive oxygen molecules that can damage cellular components, and a lack of sensitivity to insulin. Treatments that can effectively target these mechanisms could have transformational effects on the age-related diseases that are fueled by them, including potentially preventing such diseases from developing in the first place. Prof. Christian Bréchot and colleagues at The Healthy Aging Company have developed a drug candidate: ALF5755, the pharmacological name of a protein called Hepatocarcinoma-Intestine-Pancreas, or HIP for short, also named Reg3A, that has shown exciting evidence of effectiveness on the cognitive disorders which occur during Alzheimer’s disease and the peripheral nerve damage that often occurs in diabetes, which is called diabetic neuropathy.

Dr Christopher Buck | Mint: A Fresh Perspective in the Fight Against Covid

Dr Christopher Buck | Mint: A Fresh Perspective in the Fight Against Covid

Dr. Christopher Buck, a virologist at the US National Cancer Institute in Bethesda, Maryland, has been working to spread the word about a growing body of scientific literature suggesting that mint and related herbs can help fight Covid infections. In his recent review article, “The Mint Versus Covid Hypothesis,” he makes a case for the idea that decentralized clinical trials could be used to more thoroughly explore this exciting idea.

Dr Katty Kang | Deciphering the Molecular Origins of Brain Disorders

Dr Katty Kang | Deciphering the Molecular Origins of Brain Disorders

During brain development, anomalies may arise which lead to serious conditions such as epilepsy, triggering seizures and requiring lifelong monitoring and medication. However, the underlying causes and the way in which these defects occur are not completely understood. Dr Katty (Jing-Qiong) Kang and colleagues at Vanderbilt University Medical Centre in the USA have conducted extensive research into the molecular mechanisms associated with developmental brain disorders, with a focus on genetic epilepsy. They propose novel therapeutic targets to effectively manage symptoms and improve clinical outcomes by targeting the root cause.

Dr Matthew Sherrer | The Icarus Paradox in Anesthesiology: Building on Success and Avoiding Stagnation

Dr Matthew Sherrer | The Icarus Paradox in Anesthesiology: Building on Success and Avoiding Stagnation

As a medical specialty, anesthesiology has made remarkable progress to deliver patient safety at an incredibly high level, while administering drugs that could potentially be very dangerous at a slightly increased dose. However, just like the case of Icarus, a character in Greek mythology who flew too close to the sun before plummeting back to Earth, success can carry the seeds of failure. The impressive progress towards patient safety could conceivably lead to the extinction of anesthesiology as a specialty. In the context of cutting costs and an environment where the return-on-investment for anesthesiologists is not always clear, there may be a temptation to replace anesthesiologists with other professionals, such as specialized sedation nurses, or with new technologies.

 

 

 

This work is licensed under a Creative Commons Attribution 4.0 International LicenseCreative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.